Orserdu Rapid Start Program

Funded
About
The Orserdu Rapid Start Program offers a unique opportunity for patients to begin treatment quickly with Orserdu. This program is designed to assist patients who have either private or government insurance by providing a 15-day prescription of Orserdu under specific eligibility conditions. The program aims to ease access to this FDA-approved drug for new patients in the United States and Puerto Rico.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible commercially insured patients may be able to receive a 15day Orserdu prescription
Patients with government coverage must wait 5 days after a prior authorization (PA) is submitted to be eligible for this program
Completed application and required documentation should be faxed to 18333297836
For assistance or additional information, call 8334783654, Monday through Friday (9 am6 pm ET)
Other Programs

Assistance Fund: Breast Cancer

Commercially Insured
Medicare / Medicaid

Assistance Fund: Breast Cancer: Waitlist

Commercially Insured
Medicare / Medicaid
Other Tools for Orserdu